Cargando…

Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis

BACKGROUND: Human epidermal growth factor receptor (EGFR) is an oncogenic gene and one of top targets of precision therapy in lung cancer with EGFR mutations. Although there are many reports for some individual cancers, comprehensive profiling of EGFR mutations, overexpression, amplification, DNA me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haijing, Zhang, Bo, Sun, Zhifu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163653/ https://www.ncbi.nlm.nih.gov/pubmed/32067422 http://dx.doi.org/10.1002/cac2.12005

Ejemplares similares

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis
por: Yi, Qiaoli, et al.
Publicado: (2022)

An integrative pan cancer analysis of RET aberrations and their potential clinical implications
por: Zhou, Lei, et al.
Publicado: (2022)

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
por: Zhou, Zhiyang, et al.
Publicado: (2021)

An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity
por: Liu, Jian‐Nan, et al.
Publicado: (2020)

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
por: Li, Juanni, et al.
Publicado: (2020)

Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis
por: Long, Guo, et al.
Publicado: (2023)

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
por: Li, Juanni, et al.
Publicado: (2021)

Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity
por: Chen, Fei, et al.
Publicado: (2022)

An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma
por: Song, Caiyun, et al.
Publicado: (2022)

TAS2940, a novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations
por: Oguchi, Kei, et al.
Publicado: (2022)

Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study
por: Liu, Jian-Nan, et al.
Publicado: (2020)

Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
por: Mu, Long, et al.
Publicado: (2022)

Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis
por: Zhang, Xu-dong, et al.
Publicado: (2023)

Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
por: Malik, Vidhi, et al.
Publicado: (2021)

Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer
por: Zeng, Hanqian, et al.
Publicado: (2021)

Integrative proteome analysis implicates aberrant RNA splicing in impaired developmental potential of aged mouse oocytes
por: Li, Mingrui, et al.
Publicado: (2021)

Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
por: Huang, Tingting, et al.
Publicado: (2022)

Pan‐cancer molecular analysis of EGFR large fragment deletion in the Asian population
por: Pu, Jun, et al.
Publicado: (2023)

An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13
por: Zhang, Huanyu, et al.
Publicado: (2022)

Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications
por: Sun, Tao, et al.
Publicado: (2014)

Broad-spectrum pan-genus and pan-family virus vaccines
por: Tan, Chee Wah, et al.
Publicado: (2023)

Aberrant PRDM9 expression impacts the pan-cancer genomic landscape
por: Houle, Armande Ang, et al.
Publicado: (2018)

Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
por: Detilleux, Dylane, et al.
Publicado: (2022)

Pan-cancer landscape of aberrant DNA Methylation across childhood Cancers: Molecular Characteristics and Clinical relevance
por: Dong, Zheng, et al.
Publicado: (2022)

A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets
por: Fu, Xinghao, et al.
Publicado: (2022)

Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers
por: Jiangzhou, Huiting, et al.
Publicado: (2021)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers
por: Li, Zhenfen, et al.
Publicado: (2022)

Integrative analysis the characterization of peroxiredoxins in pan-cancer
por: Gao, Lei, et al.
Publicado: (2021)

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
por: Casolino, Raffaella, et al.
Publicado: (2022)

Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
por: Ju, Mingyi, et al.
Publicado: (2020)

Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer
por: Ding, Jiayu, et al.
Publicado: (2022)

The potential prognostic values of the ADAMTS-like protein family: an integrative pan-cancer analysis
por: Zhang, Xiaoyue, et al.
Publicado: (2021)

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer
por: Liu, Zekun, et al.
Publicado: (2020)

Systematic analysis of the aberrances and functional implications of cuproptosis in cancer
por: Li, Jiangbing, et al.
Publicado: (2023)

Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex
por: Federico, Antonio, et al.
Publicado: (2017)

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
por: Zhang, Qian, et al.
Publicado: (2020)

An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Wen, Huantao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fue5qivrejeliesu9bkdtffmjl